Basal Cell Carcinoma

  • Carlos Ferrándiz
  • María J. Fuente
  • Lara Ferrándiz
  • José M. Carrascosa
Part of the Cancer Treatment and Research book series (CTAR, volume 146)

Basal cell carcinoma (BCC) is a cutaneous, locally invasive, epidermal malignant tumor generally considered to originate from pluripotential immature cells of the epidermis and thus able to differentiate towards any of the epithelial skin structures. It is composed of cells similar to those in the basal layer of the epidermis and its appendages. Even though this tumor metastasizes only exceptionally [1], it causes considerable morbidity and costs to health services [2].


Transplant Recipient Skin Cancer Human Papilloma Virus Basal Cell Carcinoma Renal Transplant Recipient 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Walling HW, Fosko SW, Geraminejad PA et al. Aggressive basal cell carcinoma: presentation, pathogenesis, and management. Cancer Metastasis Rev 2004; 23:389–402PubMedCrossRefGoogle Scholar
  2. 2.
    Johnson MJ, Johnson KJ, Engel A. Prevalence, morbidity, and cost of dermatologic diseases. J Am Acad Dermatol 1984; 11:930–6PubMedCrossRefGoogle Scholar
  3. 3.
    Harden PN, Fryer AA, Reece S et al. Annual incidence and predicted risk of nonmelanoma skin cancer in renal transplant recipients. Transplant Proc 2001; 33:1302–4PubMedCrossRefGoogle Scholar
  4. 4.
    Lindelöf B, Sigurgeirsson B, Gabel H et al. Incidence of skin cancer in 5356 patients following organ transplantation. Br J Dermatol 2000; 143:513–9PubMedGoogle Scholar
  5. 5.
    Euvrard S, Kanitakis J, Claudy A. Skin cancers after organ transplantation. N Engl J Med 2003; 348:1681–91PubMedCrossRefGoogle Scholar
  6. 6.
    Ramsay HM, Fryer AA, Hawley CM et al. Non-melanoma skin cancer in the Queensland renal transplant population. Br J Dermatol 2002; 147:950–6PubMedCrossRefGoogle Scholar
  7. 7.
    Kanitakis J, Alhaj-Ibrahim L, Euvrard S et al. Basal cell carcinomas developing in solid organ transplant recipients. Arch Dermatol 2003; 139:1133–7PubMedCrossRefGoogle Scholar
  8. 8.
    Harwood CA, Proby CM, McGregor JM et al. Clinicopathologic features of skin cancer in organ transplant recipients: a retrospective case-control series. J Am Acad Dermatol 2006; 54:290–300PubMedCrossRefGoogle Scholar
  9. 9.
    Casson P. Basal cell carcinoma. Clin Plast Surg 1980; 7:301–11PubMedGoogle Scholar
  10. 10.
    Marks R. An overview of skin cancer: incidence and causation. Cancer 1995; 75:607–12PubMedCrossRefGoogle Scholar
  11. 11.
    Buettner PG, Raasch BA. Incidence rates of skin cancer in Townsville, Australia. Int J Cancer 1998; 78:587–93PubMedCrossRefGoogle Scholar
  12. 12.
    Miller DL, Weinstock MA. Nonmelanoma skin cancer in the United States: incidence. J Am Acad Dermatol 1994; 30:774–8PubMedCrossRefGoogle Scholar
  13. 13.
    Katalinic A, Kunze U, Schafer T. Epidemiology of cutaneous melanoma and non-melanoma skin cancer in Schleswig-Holstein, Germany: incidence, clinical subtypes, tumour stages and localization (epidemiology of skin cancer). Br J Dermatol 2003; 149:1200–6PubMedCrossRefGoogle Scholar
  14. 14.
    Stockfleth E, Ulrich C, Meyet T et al. Skin diseases following organ transplantation: risk factors and new therapeutic approaches. Transplant Proc 2001; 33:1848–53PubMedCrossRefGoogle Scholar
  15. 15.
    Euvrard S, Kanitakis J, Pouteil-Noble C et al. Comparative epidemiologic study of premalignant and malignant epithelial cutaneous lesions developing after kidney and heart transplantation. J Am Acad Dermatol 1995; 33:222–9PubMedCrossRefGoogle Scholar
  16. 16.
    Frezza EE, Fung JJ, van Thiel DH. Non-lymphoid cancer after liver transplantation. Hepatogastroenterology 1997; 44:1172–81PubMedGoogle Scholar
  17. 17.
    Jensen P, Hansen S, Moller B et al. Skin cancer in kidney and heart transplant recipients and different long-term immunosuppressive therapy regimens. J Am Acad Dermatol 1999; 40:177–86PubMedCrossRefGoogle Scholar
  18. 18.
    Hartevelt MM, Bavink JN, Kootte AMM et al. Incidence of skin cancer after renal transplantation in the Netherlands. Transplantation 1990; 49:506–9PubMedCrossRefGoogle Scholar
  19. 19.
    Moloney FJ, Comber H, O’Lorcain P, O’Kelly P, Conlon PJ, Murphy GM. A population-based study of skin cancer incidence and prevalence in renal transplant recipients. Br J Dermatol 2006; 154:498–504PubMedCrossRefGoogle Scholar
  20. 20.
    Webb MC, Compton F, Andrew PA et al. Skin tumors posttransplantation. A retrospective analysis of 28 years’ experience at a single center. Transplant Proc 1997; 29:828–30PubMedCrossRefGoogle Scholar
  21. 21.
    Fuente MJ, Sabat M, Roca J et al. A prospective study of the incidence of skin cancer and its risk factors in a Spanish Mediterranean population of kidney transplant recipients. Br J Dermatol 2003; 149:1221–6PubMedCrossRefGoogle Scholar
  22. 22.
    Bouwes Bavink JN, Hardie DR, Green A et al. The risk of skin cancer in renal transplant recipients in Queensland, Australia: a follow-up study. Transplantation 1996; 61:715–21CrossRefGoogle Scholar
  23. 23.
    Fortina AB, Piaserico S, Caforio ALP et al. Immunosuppressive level and other risk factors for basal cell carcinoma and squamous cell carcinoma in heart transplant recipients. Arch Dermatol 2004; 140:1079–85PubMedCrossRefGoogle Scholar
  24. 24.
    Herrero JI, España A, Quiroga J et al. Nonmelanoma skin cancer after liver transplantation. Study of risk factors. Liver Transplant 2005; 11:1100–6CrossRefGoogle Scholar
  25. 25.
    Scotto J, Kopf AW, Urbach F. Non-melanoma skin cancer among Caucasians in four areas of the United States. Cancer 1974; 34:1333–8PubMedCrossRefGoogle Scholar
  26. 26.
    Yiannias JA, Goldberg LH, Carter-Campebell S et al. The ratio of basal cell carcinoma to squamous cell carcinoma in Houston, Texas. J Dermatol Surg Oncol 1988; 14:886–9PubMedGoogle Scholar
  27. 27.
    Marks R, Jolley D, Dorevitch et al. The incidence of non-melanocytic skin cancer in an Australian population. Results of a five years prospective study. Med J Aust 1989; 150:475–8PubMedGoogle Scholar
  28. 28.
    Lampros TD, Cobanoglu A, Parker F et al. Squamous and basal cell carcinoma in heart transplant recipients. J Heart Lung Transplant 1998; 17:586–91PubMedGoogle Scholar
  29. 29.
    Ong CS, Keogh Am, Kossard S et al. Skin cancer in Australian heart transplant recipients. J Am Acad Dermatol 1999; 40;27–34PubMedCrossRefGoogle Scholar
  30. 30.
    España A, Martinez-Gonzalez MA, Garcia-Granero M et al. A prospective study of incidence nonmelanoma skin cancer in heart transplant recipients. J Invest Dermatol 2000; 115;1158–60PubMedCrossRefGoogle Scholar
  31. 31.
    Ulrich C, Schmook T, Sachse M et al. Comparative epidemiology and pathogenic factors for nonmelanoma skin cancer in organ transplant patients. Dermatol Surg 2004; 30:622–7PubMedCrossRefGoogle Scholar
  32. 32.
    Naldi L, Fortina AB, Lovati S. Risk of nonmelanoma skin cancer in Italian organ transplant recipients: a registry based study. Transplantation 2000; 70:1479–84PubMedCrossRefGoogle Scholar
  33. 33.
    Ferrándiz C, Fuente MJ, Ribera M et al. Epidermal dysplasia and neoplasia in kidney transplant recipients. J Am Acad Dermatol 1995; 33:590–6PubMedCrossRefGoogle Scholar
  34. 34.
    Levy M, Backman L, Husberg B et al. De novo malignancy following liver transplantation: a single-center study. Transplant Proc 1993; 25:1397–9PubMedGoogle Scholar
  35. 35.
    Caforio AL, Fortina AB, Piaserico S et al. Skin cancer in heart transplant recipients: risk factor analysis and relevance of immunosuppressive therapy. Circulation 2000; 102(suppl 3):222–27Google Scholar
  36. 36.
    España A, Redondo P, Fernández AL, et al. Skin cancer in heart transplant recipients. J Am Acad Dermatol 1995; 32:458–65PubMedCrossRefGoogle Scholar
  37. 37.
    Euvrard S, Kanitakis J, Cochat P et al. Skin cancers following organ transplantation. Dermatol Surg 2004; 30:616–21PubMedCrossRefGoogle Scholar
  38. 38.
    Menni S, Beretta D, Piccino R et al. Cutaneous and oral lesions in 32 children after renal transplantation. Pediatr Dermatol 1991; 8:194–8PubMedCrossRefGoogle Scholar
  39. 39.
    Halper E, Tunnessen WW, Fivush B et al. Cutaneous lesions associated with cyclosporine therapy in pediatric renal transplant recipients. J Pediatr 1991; 119:489–91CrossRefGoogle Scholar
  40. 40.
    Euvrard S, Kanitakis J, Cochat P et al. Skin diseases in children with organ transplants. J Am Acad Dermatol 2001; 44:932–9PubMedCrossRefGoogle Scholar
  41. 41.
    Rubin A, Chen AH, Ratner D. Basal cell carcinoma. N Engl J Med 2005; 353:2262–9PubMedCrossRefGoogle Scholar
  42. 42.
    Sexton M, Jones DB, Maloney ME. Histologic pattern analysis of basal cell carcinoma. Study of a series of 1039 consecutive neoplasms. J Am Acad Dermatol 1990; 23:1118–26PubMedCrossRefGoogle Scholar
  43. 43.
    Habets JMW, Tank B, Vuzevski VD. Characterization of the mononuclear cell infiltrate in basal cell carcinoma: a predominantly T cell-mediated immune response with minor participation of Leu-7+ (natural killer) cells and Leu-14+ (B) cells. J Invest Dermatol 1988; 90:289–292.PubMedCrossRefGoogle Scholar
  44. 44.
    Batra RS, Kelley LC. Predictors of extensive subclinical spread in nonmelanoma skin cancer treated with Mohs micrographic surgery. Arch Dermatol 2002; 138:1043–51PubMedCrossRefGoogle Scholar
  45. 45.
    Parnes R, Safai B, Myskowski PL. Basal cell carcinoma and lymphoma: biological behavior and associated factors in sixty-three patients. J Am Acad Dermatol 1988; 19:1017–23PubMedCrossRefGoogle Scholar
  46. 46.
    Smith KJ, Skelton HG, Yeager J et al. Cutaneous neoplasms in a military population of HIV-1 patients. J Am Acad Dermatol 1993; 29:400–6PubMedCrossRefGoogle Scholar
  47. 47.
    Oram Y, Orengo I, Griego RD et al. Histologic patterns of basal cell carcinoma based upon patient immunostatus. Dermatol Surg 1995; 21:611–4PubMedCrossRefGoogle Scholar
  48. 48.
    Bastiaens MT, Hoefnagel JJ, Bruijn JA et al. Differences in age, site distribution, and sex between nodular and superficial basal cell carcinomas indicate different types of tumours. J Invest Dermatol 1998; 110:880–4PubMedCrossRefGoogle Scholar
  49. 49.
    Raasch BA, Buettner PG, Garbe C. Basal cell carcinoma: histological classification and body-site distribution. Br J Dermatol 2006; 155:401–7PubMedCrossRefGoogle Scholar
  50. 50.
    Lefell DJ, Headington JT, Wong D et al. Aggressive growth basal cell carcinoma in young adults. Arch Dermatol 1991; 127:1663–7CrossRefGoogle Scholar
  51. 51.
    Corona R, Dogliotti E, D’Errico M et al. Risk factors for basal cell carcinoma in a Mediterranean population: role of recreational sun exposure early in life. Arch Dermatol 2001; 137:116–8Google Scholar
  52. 52.
    Kricker A, Armstrong BK, English DR et al. Does intermittent exposure cause basal cell carcinoma? A case-control study in Western Australia. Int J Cancer 1995; 60:489–94PubMedCrossRefGoogle Scholar
  53. 53.
    Ramsay HM, Fryer AA, Hawley CM et al. Factors associated with non-melanoma skin cancer following renal transplantation in Queensland, Australia. J Am Acad Dermatol 2003; 49:397–406PubMedCrossRefGoogle Scholar
  54. 54.
    Bouwes Bavink JN, Kootte Am, Van der Woude FJ et al. HLA-A11-associated resistance to skin cancer in renal transplant recipients. N Engl J Med 1990; 323:1350Google Scholar
  55. 55.
    Bouwes Bavink JN, Claas FHJ, Hardie DR et al. Relation between HA antigens and skin cancer in renal transplant recipients in Queensland. Aust J Invest Dermatol 1997; 108:708–11CrossRefGoogle Scholar
  56. 56.
    McGregor JM, Reddi G, NacDonald D et al. HLA-A11 in renal allograft recipients with skin cancer. J Invest Dermatol 1991; 98:261–2CrossRefGoogle Scholar
  57. 57.
    Czarnecki D, Watkins F, Leahy S et al. Skin cancer and HLA frequencies in renal transplant recipients. Dermatology 1992; 185:9–11PubMedGoogle Scholar
  58. 58.
    Rompel R, Petres J, Kaupert K et al. HLA phenotype and multiple basal cell carcinomas. Dermatology 1994; 189:222–4PubMedCrossRefGoogle Scholar
  59. 59.
    Zanetti R, Rosso S, Martinez C et al. Comparison of risk patterns in carcinoma and melanoma of the skin in men: a multi-centre case-case-control study. Br J Cancer 2006; 94:743–51PubMedGoogle Scholar
  60. 60.
    Lear JT, Tan BB, Smith AG et al. Risk factors for basal cell carcinoma in the UK: case-control study in 806 patients. J R Soc Med 1997; 90:371–4.PubMedGoogle Scholar
  61. 61.
    Vitasa BC, Taylor HR, Strickland PT et al. Association of nonmelanoma skin cancer and actinic keratosis with cumulative solar ultraviolet exposure in Maryland watermen. Cancer 1990; 65:2811–7PubMedCrossRefGoogle Scholar
  62. 62.
    Caroll RP, Ramsay HM, Fryer AA et al. Incidence and prediction of nonmelanoma skin cancer post-renal transplantation. A prospective study in Qeensland, Australia. Am J Kidney Dis 2003; 41:676–83CrossRefGoogle Scholar
  63. 63.
    Dantal J, Hourmant N, Cantarovih D et al. Long term immunosuppression in kidney-graft recipients on cancer incidence: randomised comparison of two cyclosporine regimens. Lancet 1998; 351:623–28PubMedCrossRefGoogle Scholar
  64. 64.
    Ducloux D, Carron PL, Rebibou JM et al. CD4 lymphocytopenia as a risk factor for skin cancers in renal transplant recipients. Transplantation 1998; 65:1270–2.PubMedCrossRefGoogle Scholar
  65. 65.
    Jemec GB, Holm EA. Nonmelanoma skin cancer in organ transplant recipients. Transplantation 2003; 75:253–7PubMedCrossRefGoogle Scholar
  66. 66.
    Glover MT, Deeks JJ, Raftery MJ et al. Immunosuppression and the risk of nonmelanoma skin cancer in renal transplant recipients. Lancet 1997; 349:398PubMedCrossRefGoogle Scholar
  67. 67.
    Marcen R, Pascual J Tato AM et al. Influence of immunosuppression on the prevalence of cancer after kidney transplantation. Transplant Proc 2003; 35:1714–6PubMedCrossRefGoogle Scholar
  68. 68.
    Mithoefer AB, Supran S, Freeman RB. Risk factors associated with the development of skin cancer after liver transplantation. Liver Transplant 2002; 8:939–44CrossRefGoogle Scholar
  69. 69.
    Campistol JM, Eris J, Oberbauer R et al. Sirolimus therapy after early cyclosporine withdrawal reduces the risk for cancer in adult renal transplantation. J Am Soc Nephrol 2006; 17:581–9PubMedCrossRefGoogle Scholar
  70. 70.
    Mathew T, Kreis H, Friend P. Two year incidence of malignancy in sirolimus treated renal transplant recipients: results from five multicenter studies. Clin Transplant 2004; 18:446–9PubMedCrossRefGoogle Scholar
  71. 71.
    Euvrard S, Chardonnet Y, Pouteil-Noble C et al. Association of skin malignancies with various and multiple carcinogenic and non-carcinogenic human papillomavirus in renal transplant recipients. Cancer 1993; 72:2198–206PubMedCrossRefGoogle Scholar
  72. 72.
    Lindelöf B, Granath F, Dal H et al. Sun habits in kidney transplant recipients with skin cancer: a case control study of possible causative factors. Acta Dermatol Venerol 2003; 83:189–93CrossRefGoogle Scholar
  73. 73.
    Harwood CA, Surentheran T, McGregor JM et al. Human papillomavirus infection and non-melanoma skin cancer in immunosuppressed and immunocompetent individuals, J Virol 2000; 61:289–97CrossRefGoogle Scholar
  74. 74.
    Berkhout R, Bouwes-Bavink JN, ter Scchegget J. Persistence of human papillomavirus DNA in benign and (pre)malignant skin lesions from renal transplant recipients. J Clin Microbiol 2000; 38:2087–96PubMedGoogle Scholar
  75. 75.
    Wieland U, Ritzkowsky A, Stoltidis M et al. Papillomavirus DNA in basal cell carcinomas of immunocompetent patients: an accidental association? J Invest Dermatol 2000; 115:124–8PubMedCrossRefGoogle Scholar
  76. 76.
    Stockfleth E, Nindl I, Sterry W et al. Human papilloma viruses in transplant-associated skin cancers. Dermatol Surg 2004; 30:4:604–9PubMedCrossRefGoogle Scholar
  77. 77.
    Shamanin V, Zur Hausen H, Lavergne D et al. Human papillomavirus infections in nonmelanoma skin cancers from renal transplant recipients and nonimmunosuppressed patients. J Natl Cancer Inst 1996; 88:802–11PubMedCrossRefGoogle Scholar
  78. 78.
    Karagas MR, Nelson HH, Sehr P et al. Human papillomavirus infection and incidence of squamous and basal cell carcinomas of the skin. J Natl Cancer Inst 2006; 98:389–95PubMedCrossRefGoogle Scholar
  79. 79.
    Telfer NR, Colver GB, Bowers PW. Guidelines for the management of basal cell carcinoma. Br J Dermatol 1999; 141:415–23PubMedCrossRefGoogle Scholar
  80. 80.
    Rowe DE. Comparison of treatment modalities for basal cell carcinoma. Clin Dermatol 1995; 13:617–20PubMedCrossRefGoogle Scholar
  81. 81.
    Silverman MK, Kopf AV, Grin CM, Bart RS, Levenstein MJ. Recurrence rates of treated basal cell carcinomas. Part 2: Curretage-electrodessication. J Dermatol Surg Oncol 1991; 17:720–6PubMedGoogle Scholar
  82. 82.
    Kuflik EG, Gage A. The five-year cure rate achieved by cryosurgery for akin cancer. J Am Acad Dermatol 1991; 24:1002–4PubMedCrossRefGoogle Scholar
  83. 83.
    Peng Q, Warloe T, Berg K, Moan J, Kongshaug M, Giercksky KE et al. 5-Aminolevulinic acid-based photodynamic therapy. Cancer 1997; 79:2282–308PubMedCrossRefGoogle Scholar
  84. 84.
    Marks R, Gebauer K, Shumak S, Amies M, Bryden J, Fox TL et al. Imiquimod 5% cream in the treatment of superficial basal cell carcinoma: results of a multicentre 6 week dose-response trial. J Am Acad Dermatol 2001; 44:807–13PubMedCrossRefGoogle Scholar
  85. 85.
    Stockfleth E, Ulrich C, Meyer T, Christophers E. Epithelial malignancies in organ transplant patients: clinical presentation and new methods of treatment. Recent Results Cancer Res 2002; 160:251–8PubMedGoogle Scholar
  86. 86.
    De Graaf YGL, Euvrard S, Bouwes Bvinck JN. Systemic and topical retinoids in the management of skin cancer in organ transplant recipients. Dermatol Surg 2004; 30:656–61PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2009

Authors and Affiliations

  • Carlos Ferrándiz
    • 1
    • 2
  • María J. Fuente
    • 1
  • Lara Ferrándiz
    • 3
  • José M. Carrascosa
    • 1
  1. 1.Department of DermatologyHospital Universitario Germans Trias i PujolBadalonaSpain
  2. 2.Universidad Autónoma of BarcelonaBarcelonaSpain
  3. 3.Department of DermatologyHospital Universitario Virgen Macarena, Universidad of SevillaSevillaSpain

Personalised recommendations